Lumos Diagnostics Holdings Limited

ASX:LDX Stock Report

Market Cap: AU$18.7m

Lumos Diagnostics Holdings Future Growth

Future criteria checks 2/6

Lumos Diagnostics Holdings is forecast to grow earnings and revenue by 37% and 21.8% per annum respectively while EPS is expected to grow by 45.5% per annum.

Key information

37.0%

Earnings growth rate

45.5%

EPS growth rate

Medical Equipment earnings growth15.4%
Revenue growth rate21.8%
Future return on equityn/a
Analyst coverage

Low

Last updated28 Mar 2025

Recent future growth updates

Recent updates

Lacklustre Performance Is Driving Lumos Diagnostics Holdings Limited's (ASX:LDX) 29% Price Drop

Mar 07
Lacklustre Performance Is Driving Lumos Diagnostics Holdings Limited's (ASX:LDX) 29% Price Drop

Lumos Diagnostics Holdings Limited's (ASX:LDX) Share Price Boosted 31% But Its Business Prospects Need A Lift Too

Jan 20
Lumos Diagnostics Holdings Limited's (ASX:LDX) Share Price Boosted 31% But Its Business Prospects Need A Lift Too

Lumos Diagnostics Holdings Limited (ASX:LDX) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Nov 28
Lumos Diagnostics Holdings Limited (ASX:LDX) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Lumos Diagnostics Holdings Limited (ASX:LDX) Stock Catapults 35% Though Its Price And Business Still Lag The Industry

Oct 14
Lumos Diagnostics Holdings Limited (ASX:LDX) Stock Catapults 35% Though Its Price And Business Still Lag The Industry

There Is A Reason Lumos Diagnostics Holdings Limited's (ASX:LDX) Price Is Undemanding

Aug 29
There Is A Reason Lumos Diagnostics Holdings Limited's (ASX:LDX) Price Is Undemanding

Take Care Before Diving Into The Deep End On Lumos Diagnostics Holdings Limited (ASX:LDX)

Jan 03
Take Care Before Diving Into The Deep End On Lumos Diagnostics Holdings Limited (ASX:LDX)

The Market Lifts Lumos Diagnostics Holdings Limited (ASX:LDX) Shares 387% But It Can Do More

Jul 04
The Market Lifts Lumos Diagnostics Holdings Limited (ASX:LDX) Shares 387% But It Can Do More

Bearish: Analysts Just Cut Their Lumos Diagnostics Holdings Limited (ASX:LDX) Revenue and EPS estimates

Jul 12
Bearish: Analysts Just Cut Their Lumos Diagnostics Holdings Limited (ASX:LDX) Revenue and EPS estimates

Earnings and Revenue Growth Forecasts

ASX:LDX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202724-2111
6/30/202618-3-1-11
6/30/202514-6-4-41
12/31/202415-5-1-1N/A
9/30/202413-700N/A
6/30/202411-911N/A
3/31/202410-9-4-4N/A
12/31/20238-9-9-9N/A
9/30/20239-9-9-9N/A
6/30/202311-9-10-10N/A
3/31/202311-25-12-11N/A
12/31/202212-41-13-12N/A
9/30/202212-43-18-15N/A
6/30/202212-46-22-18N/A
3/31/202214-34-24-17N/A
12/31/202116-23-25-15N/A
9/30/202117-19-22-13N/A
6/30/202119-15-19-11N/A
3/31/202116-12-17-9N/A
12/31/202012-9-15-7N/A
9/30/20209-9-13-6N/A
6/30/20206-9-10-4N/A
6/30/20194-5-6-3N/A
6/30/20182-1N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: LDX is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: LDX is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: LDX is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: LDX's revenue (21.8% per year) is forecast to grow faster than the Australian market (5.6% per year).

High Growth Revenue: LDX's revenue (21.8% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if LDX's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/23 07:45
End of Day Share Price 2025/04/23 00:00
Earnings2024/12/31
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lumos Diagnostics Holdings Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Chris KallosMST Financial Services Pty Limited